Abstract:Objetivou-se, com este estudo, avaliar os efeitos da buprenorfina sobre variáveis cardiovasculares e respiratórias em cães durante anestesia com desfluorano. Para tanto, foram utilizados 20 cães adultos, distribuídos em dois grupos (GB e GC). A anestesia foi induzida com propofol (8mg kg-1 IV) e em seguida os animais foram intubados com sonda de Magill, a qual foi conectada ao aparelho de anestesia para administração de desfluorano (1,5 CAM). Após 30 minutos, foi aplicado no GB buprenorfina (0,02mg kg-1) e no … Show more
“…In G1, however, a value greater than normal was observed at M4 what is probably associated to the reduction in V M and SatO2, as a result of the alterations brought about by xylazine 11 , confirmed when intramuscular ketamine and xylazine injection was used. In both groups the cardiac frequency (CF) behavior was similar showing a slight decrease, but within the physiological limits, as reported for pre-treated dogs with intravenous buprenorphine 28 leading to. This reduction can be associated to the depressing effects of methotrimeprazine 29 by a CF decrease in pre-treated dogs with methotrimeprazine and treated with a-2 agonists, probably due to the increasing tachycardia effect caused by ketamine through the direct synaptic stimulation by elevation of circulating norepinephrine.…”
PURPOSE: To compare, by continuous infusion of ketamine or medetomidine combined to methotrimeprazine and buprenorphine, ketamine and midazolam, the degree of hypnosis, myorelaxation, anesthetic quality and surgical feasibility through evaluation of possible parametric alterations and recovery quality. METHODS: 20 healthy adult females dogs, aged 3 to 5 years, body weight between 7 and 15 kg, were assigned randomly and homogenously to 2 groups of 10 animals each (n=10), group 1 (G1) and group 2 (G2), respectively. Animals of G1 were subjected to a pre-treatment with intravenous 1.0 mg/kg methotrimeprazine and or 3ì/kg. After 15 minutes, a 5.0 mg/kg ketamine and 0.2 mg/kg midazolam were intravenously injected. Immediately after induction, an anesthetic combination of 0.4 mg/kg/h midazolam, 20 mg/kg/h ketamine and 1.0 mg/kg/h xylazine, was continuously and intravenously administered for 30 minutes. The same techniques were used in G2 except for the substitution of xylazine for 30ìg/kg/h medetomidine. RESULTS: In G1 there was a 1st and 2nd degree atrioventricular heart block, a longer recovery period and lower quality. In G2 a 1st degree atrioventricular heart block occurred but isolated and ephemeral. CONCLUSIONS: The continuous infusion method, besides reducing drugs utilization, prevented collateral effects allowing a more tranquil recovery with no excitations, both protocols permitted the surgical procedure (ovary-hysterectomy) bringing about a reduction in hypnosis and an accentuated myorelaxation. Xylazine and medetomidine showed a similar pharmacodynamic behavior but with different clinical aspects. The electrocardiographic alterations observed in G2 and in a lower degree in G1 must be well studied. Describers: dogs, ketamine, methotrimeprazine, medetomidine, midazolam and xylazine.
“…In G1, however, a value greater than normal was observed at M4 what is probably associated to the reduction in V M and SatO2, as a result of the alterations brought about by xylazine 11 , confirmed when intramuscular ketamine and xylazine injection was used. In both groups the cardiac frequency (CF) behavior was similar showing a slight decrease, but within the physiological limits, as reported for pre-treated dogs with intravenous buprenorphine 28 leading to. This reduction can be associated to the depressing effects of methotrimeprazine 29 by a CF decrease in pre-treated dogs with methotrimeprazine and treated with a-2 agonists, probably due to the increasing tachycardia effect caused by ketamine through the direct synaptic stimulation by elevation of circulating norepinephrine.…”
PURPOSE: To compare, by continuous infusion of ketamine or medetomidine combined to methotrimeprazine and buprenorphine, ketamine and midazolam, the degree of hypnosis, myorelaxation, anesthetic quality and surgical feasibility through evaluation of possible parametric alterations and recovery quality. METHODS: 20 healthy adult females dogs, aged 3 to 5 years, body weight between 7 and 15 kg, were assigned randomly and homogenously to 2 groups of 10 animals each (n=10), group 1 (G1) and group 2 (G2), respectively. Animals of G1 were subjected to a pre-treatment with intravenous 1.0 mg/kg methotrimeprazine and or 3ì/kg. After 15 minutes, a 5.0 mg/kg ketamine and 0.2 mg/kg midazolam were intravenously injected. Immediately after induction, an anesthetic combination of 0.4 mg/kg/h midazolam, 20 mg/kg/h ketamine and 1.0 mg/kg/h xylazine, was continuously and intravenously administered for 30 minutes. The same techniques were used in G2 except for the substitution of xylazine for 30ìg/kg/h medetomidine. RESULTS: In G1 there was a 1st and 2nd degree atrioventricular heart block, a longer recovery period and lower quality. In G2 a 1st degree atrioventricular heart block occurred but isolated and ephemeral. CONCLUSIONS: The continuous infusion method, besides reducing drugs utilization, prevented collateral effects allowing a more tranquil recovery with no excitations, both protocols permitted the surgical procedure (ovary-hysterectomy) bringing about a reduction in hypnosis and an accentuated myorelaxation. Xylazine and medetomidine showed a similar pharmacodynamic behavior but with different clinical aspects. The electrocardiographic alterations observed in G2 and in a lower degree in G1 must be well studied. Describers: dogs, ketamine, methotrimeprazine, medetomidine, midazolam and xylazine.
“…Segundo Luna (22) , o bicarbonato é responsável por mais de 50% da capacidade-tampão extracelular. A concentração de bicarbonato plasmático está diretamente relacionada à elevação na PaCO2 (Tabela 1), pois o mecanismo compensatório eleva as taxas de bicarbonato a fim de neutralizar o excesso de CO2 presente no sangue (23) .…”
Resumo A fitoterapia vem sendo utilizada em criação de peixes a fim de promover estabilidade no ambiente de cultivo e na profilaxia de doenças, contribuindo para a melhoria do bem-estar animal. Dentre os fitoterápicos, Erythrina crista-galli tem efeito sedativo e atividade antioxidante e antimicrobiana, além de funcionar como calmante natural. Na ausência de formulações para uso em peixes cultivados, surgem protocolos terapêuticos repletos de incertezas quanto à sua eficácia, ao impacto ambiental e ao perfil hematológico dos peixes. No ensaio de tolerância aguda da Erythrina crista-galli, foram utilizados exemplares de Carassius auratus, expostos às concentrações de controle (zero), 50, 100 e 200 mgL-1, com três repetições, por 96 horas. Foi observada a sobrevivência de 100% em todos os tratamentos. Estes resultados revelam que o extrato de Erythrina crista-galli não apresenta toxicidade para peixes. O balanço eletrolítico plasmático não apresentou mudanças. A utilização de até 100 mgL-1 não promoveu mudanças na trocas gasosas. O pH e a concentração de bicarbonato e glicose foram crescentes até a concentração de 100 mgL-1. Conclui-se que a utilização de Erythrina crista-galli para exposição aguda de Carassius auratus não promove mortalidade, mas provoca alterações indesejáveis nos parâmetros fisiológicos sanguíneos quando utilizadas doses acima de 100 mgL-1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.